ARCHIVES

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

No Proof Fiber Is Anticarcinogenic, Newell Says, But diet should Include Anyway

May 18, 1979

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999

Univ. Of Pittsburgh Plans Molecular Medicine Institute.

January 25, 2002

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980